Safety and Tolerability of Lu AG06479 in Healthy Young Men

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

The purpose of this study is to investigate the safety and tolerability of Lu AG06479 and what the body does to Lu AG06479 after swallowing single doses of the drug.

Key facts

Study ID

NCT04473651

Run by

H. Lundbeck A/S

People needed

46

Starts

2020-07-09

Expected to finish

2021-11-10

Last updated by the study team

2021-12-14

Who can join

Age: 18 and older, up to 45. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Healthy, young, non-smoking men, weight ≥60 kg, and a body mass index (BMI) ≥18.5 kg/m2 and ≤30 kg/m2 at the Screening Visit.
• Other in- and exclusion criteria may apply

Where it is running

• Covance — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.